Cenci MA - Search Results

1

Cells, pathways, and models in dyskinesia research.

Cenci MA, Kumar A. Cenci MA, et al. Curr Opin Neurobiol. 2024 Feb;84:102833. doi: 10.1016/j.conb.2023.102833. Epub 2024 Jan 6. Curr Opin Neurobiol. 2024. PMID: 38184982 Free article. Review.

2

Advances in understanding L-DOPA-induced dyskinesia.

Cenci MA, Lindgren HS. Cenci MA, et al. Curr Opin Neurobiol. 2007 Dec;17(6):665-71. doi: 10.1016/j.conb.2008.01.004. Epub 2008 Mar 4. Curr Opin Neurobiol. 2007. PMID: 18308560 Review.

3

mGlu receptors in the treatment of Parkinson's disease and L-DOPA-induced dyskinesia.

Sebastianutto I, Cenci MA. Sebastianutto I, et al. Among authors: cenci ma. Curr Opin Pharmacol. 2018 Feb;38:81-89. doi: 10.1016/j.coph.2018.03.003. Epub 2018 Apr 3. Curr Opin Pharmacol. 2018. PMID: 29625424 Review.

4

Animal models of l-dopa-induced dyskinesia in Parkinson's disease.

Cenci MA, Crossman AR. Cenci MA, et al. Mov Disord. 2018 Jul;33(6):889-899. doi: 10.1002/mds.27337. Epub 2018 Feb 28. Mov Disord. 2018. PMID: 29488257 Review.

5

Validation of an improved scale for rating l-DOPA-induced dyskinesia in the mouse and effects of specific dopamine receptor antagonists.

Sebastianutto I, Maslava N, Hopkins CR, Cenci MA. Sebastianutto I, et al. Among authors: cenci ma. Neurobiol Dis. 2016 Dec;96:156-170. doi: 10.1016/j.nbd.2016.09.001. Epub 2016 Sep 2. Neurobiol Dis. 2016. PMID: 27597526

6

On the neuronal circuitry mediating L-DOPA-induced dyskinesia.

Cenci MA, Jörntell H, Petersson P. Cenci MA, et al. J Neural Transm (Vienna). 2018 Aug;125(8):1157-1169. doi: 10.1007/s00702-018-1886-0. Epub 2018 Apr 27. J Neural Transm (Vienna). 2018. PMID: 29704061 Free PMC article. Review.

7

Dyskinesia matters.

Cenci MA, Riggare S, Pahwa R, Eidelberg D, Hauser RA. Cenci MA, et al. Mov Disord. 2020 Mar;35(3):392-396. doi: 10.1002/mds.27959. Epub 2019 Dec 24. Mov Disord. 2020. PMID: 31872501

8

Dramatic differences in susceptibility to l-DOPA-induced dyskinesia between mice that are aged before or after a nigrostriatal dopamine lesion.

Bez F, Francardo V, Cenci MA. Bez F, et al. Among authors: cenci ma. Neurobiol Dis. 2016 Oct;94:213-25. doi: 10.1016/j.nbd.2016.06.005. Epub 2016 Jun 14. Neurobiol Dis. 2016. PMID: 27312773

9

Activity of serotonin 5-HT(1A) receptor 'biased agonists' in rat models of Parkinson's disease and L-DOPA-induced dyskinesia.

Iderberg H, McCreary AC, Varney MA, Cenci MA, Newman-Tancredi A. Iderberg H, et al. Among authors: cenci ma. Neuropharmacology. 2015 Jun;93:52-67. doi: 10.1016/j.neuropharm.2015.01.012. Epub 2015 Jan 31. Neuropharmacology. 2015. PMID: 25645393

10

L-DOPA-induced dyskinesia: cellular mechanisms and approaches to treatment.

Cenci MA. Cenci MA. Parkinsonism Relat Disord. 2007;13 Suppl 3:S263-7. doi: 10.1016/S1353-8020(08)70014-2. Parkinsonism Relat Disord. 2007. PMID: 18267248 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

140 results

Search Page